CD34+ Stem Cell Enumeration
UKAS accredited - Proficiency testing provider No. 7804This programme is operated by UK NEQAS Leucocyte Immunophenotyping. The centre provides flow cytometry and molecular haematology based programmes. For further information on the operation of the programme or details on current accreditation status please contact UK NEQAS Leucocyte Immunophenotyping directly.
Telephone: +44 (0) 114 267 3600
CD34+ stem cell enumeration
PURPOSE OF PROGRAMME:
To assess a laboratory's ability to detect CD34+ stem cells in patients awaiting peripheral blood stem cell harvest
|cd34||cells/µL (absolute count) and percentages|
MATERIAL PROVIDED: Stabilised whole blood
DISTRIBUTIONS PER YEAR: Minimum 4; Maximum 6
SAMPLES PER DISTRIBUTION: Trial is web based – No samples are issued to participants
FREQUENCY OF DISTRIBUTION: Bimonthly as per Trial Schedule (Please note – The Trial Schedule is a guide only and is subject to change)
PROGRAMME OF ANALYSIS:
Results are entered online via the UK NEQAS LI website. Trials are live for 3 weeks. Results can be entered at any time during this period. Under exceptional circumstances late results are accepted at our discretion via email/fax.
Quantitative analysis. Results are scores against the consensus (defined as the robust mean) absolute counts from results submitted by participants using the single platform ISHAGE gating strategy
z scores using robust means and robust SDs with standard limits of +2 and +3 and -2 and -3 as per ISO 13528 A result between 2.0 and -2.0 would be classed as satisfactory. A result between >2.0 and 3.0 or <-2.0 and -3.0 is seen as an 'Action' result, which highlights a potential issue to the laboratory. Two 'Action' results in a period of 3 samples would result in classification as a 'Critical'. A result above 3.0 or below -3.0 is considered to be a 'Critical' result requiring immediate inves
Participant performance is monitored by means of a rolling n+1 sample window where n equals the number of samples per trial issue.
PERSISTENT POOR PERFORMANCE:
Three 'Critical' classifications in a 12 month period are classed as Persistent Unsatisfactory Performance.
LEUCOCYTE IMMUNOPHENOTYPING The External Quality Assessment Scheme for Leucocyte Immunophenotyping was established by Professor David Barnett in 1986 at Northern General Hospital, Sheffield. In 1990 the Service became known as the UK National External Quality Assessment Service for Leucocyte Immunophenotyping. UK NEQAS LI is part of the Sheffield Teaching Hospitals NHS Foundation Trust. The centre currently provides flow cytometry and molecular haematology based programmes.